Analysts Set Alexandria Real Estate Equities, Inc. (NYSE:ARE) Target Price at $51.92

Shares of Alexandria Real Estate Equities, Inc. (NYSE:ARE) have been assigned a consensus rating of “Hold” from the sixteen analysts that are currently covering the firm, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell recommendation, eleven have issued a hold recommendation and three have issued a buy recommendation on the company. The average 1-year target price among brokerages that have issued ratings on the stock in the last year is $51.9231.

A number of equities research analysts have recently issued reports on ARE shares. Zacks Research upgraded Alexandria Real Estate Equities from a “strong sell” rating to a “hold” rating in a report on Thursday, January 29th. Royal Bank Of Canada reduced their price objective on Alexandria Real Estate Equities from $60.00 to $50.00 and set a “sector perform” rating for the company in a report on Tuesday, May 5th. Evercore set a $55.00 price objective on Alexandria Real Estate Equities in a report on Monday, May 4th. BMO Capital Markets restated a “market perform” rating and set a $52.00 price objective (down from $65.00) on shares of Alexandria Real Estate Equities in a report on Wednesday, March 25th. Finally, Robert W. Baird restated a “neutral” rating and set a $46.00 price objective (down from $67.00) on shares of Alexandria Real Estate Equities in a report on Monday, May 4th.

Alexandria Real Estate Equities Trading Down 2.7%

Shares of NYSE:ARE opened at $44.93 on Friday. Alexandria Real Estate Equities has a 12-month low of $39.41 and a 12-month high of $88.24. The stock has a market cap of $7.83 billion, a PE ratio of -7.17, a P/E/G ratio of 5.59 and a beta of 1.12. The business has a 50 day moving average of $46.49 and a 200-day moving average of $50.72. The company has a quick ratio of 0.20, a current ratio of 0.20 and a debt-to-equity ratio of 0.65.

Alexandria Real Estate Equities (NYSE:ARE) last issued its quarterly earnings data on Monday, April 27th. The real estate investment trust reported $1.73 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $1.73. Alexandria Real Estate Equities had a negative return on equity of 5.21% and a negative net margin of 36.03%.The company had revenue of $671.02 million during the quarter, compared to analysts’ expectations of $684.78 million. During the same quarter in the previous year, the company posted $2.30 earnings per share. The business’s revenue was down 11.5% on a year-over-year basis. Alexandria Real Estate Equities has set its FY 2026 guidance at 6.300-6.500 EPS. As a group, equities research analysts forecast that Alexandria Real Estate Equities will post 6.4 earnings per share for the current year.

Alexandria Real Estate Equities Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, April 15th. Stockholders of record on Tuesday, March 31st were issued a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 6.4%. The ex-dividend date was Tuesday, March 31st. Alexandria Real Estate Equities’s payout ratio is currently -45.93%.

Insider Activity at Alexandria Real Estate Equities

In related news, EVP Hallie E. Kuhn sold 536 shares of the business’s stock in a transaction that occurred on Friday, April 17th. The stock was sold at an average price of $48.20, for a total value of $25,835.20. Following the completion of the sale, the executive vice president directly owned 48,301 shares in the company, valued at approximately $2,328,108.20. The trade was a 1.10% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gregory Calvin Thomas purchased 3,500 shares of the business’s stock in a transaction that occurred on Thursday, April 30th. The stock was bought at an average price of $41.00 per share, with a total value of $143,500.00. Following the completion of the purchase, the executive vice president owned 33,024 shares of the company’s stock, valued at $1,353,984. This trade represents a 11.85% increase in their position. The SEC filing for this purchase provides additional information. 1.35% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Alexandria Real Estate Equities

Several institutional investors have recently made changes to their positions in the stock. Lazard Asset Management LLC bought a new stake in shares of Alexandria Real Estate Equities in the first quarter valued at approximately $13,540,000. Weiss Asset Management LP bought a new stake in shares of Alexandria Real Estate Equities in the first quarter valued at approximately $3,672,000. OMERS ADMINISTRATION Corp boosted its stake in shares of Alexandria Real Estate Equities by 4.3% in the first quarter. OMERS ADMINISTRATION Corp now owns 6,149 shares of the real estate investment trust’s stock valued at $285,000 after buying an additional 252 shares during the period. Healthcare of Ontario Pension Plan Trust Fund boosted its stake in shares of Alexandria Real Estate Equities by 4,321.4% in the first quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 271,826 shares of the real estate investment trust’s stock valued at $12,618,000 after buying an additional 265,678 shares during the period. Finally, Arrowstreet Capital Limited Partnership bought a new stake in shares of Alexandria Real Estate Equities in the first quarter valued at approximately $36,618,000. 96.54% of the stock is currently owned by institutional investors.

Alexandria Real Estate Equities Company Profile

Alexandria Real Estate Equities, Inc (NYSE: ARE) is a real estate investment trust specializing in the ownership, development and management of collaborative life science and technology campuses. The company’s properties are designed to support research and innovation by providing specialized laboratory, office and manufacturing space tailored to biotechnology, pharmaceutical, academic and related industries.

Since its founding in 1994, Alexandria has cultivated a diversified portfolio of campuses across leading innovation clusters in North America and Europe.